Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Copper meso-5,15-bis[3-[(1,2-dicarba-closo-dodecaboranyl)methoxy]phenyl]-meso-10,20-dinitroporphyrin

EU orphan designation number: EU/3/13/1138   
Active ingredient: Copper meso-5,15-bis[3-[(1,2-dicarba-closo-dodecaboranyl)methoxy]phenyl]-meso-10,20-dinitroporphyrin
Indication: Treatment of squamous cell carcinoma of the head and neck in patients undergoing radiotherapy
Sponsor: MorEx Development Partners LLP
c/o Blue Rock Services Ltd ,63 St. James's Street, London ,SW1A 1LY United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/07/2013 Orphan Designation EMA/OD/022/13 (2013)4165 of 27/06/2013
22/07/2014 Change of address of sponsor